Cite
MLA Citation
Charles Miller et al.. “Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab.” Frontline gastroenterology, vol. 13, no. 5, 2022, pp. 392–401. http://access.bl.uk/ark:/81055/vdc_100160171801.0x000044